Status:

UNKNOWN

Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.

Lead Sponsor:

Wanqing Gu

Conditions:

Systemic Inflammatory Response Syndrome

Jaundice, Obstructive

Eligibility:

All Genders

18-80 years

Phase:

PHASE1

PHASE2

Brief Summary

RATIONALE:Anticholinesterase drugs and cholinergic M receptor antagonist are applied to patients who have obstructive jaundice after operation. PURPOSE:This clinical trial was designed to lower the i...

Detailed Description

OBJECTIVES: Ⅰ.Judge whether it has the effect of inhibiting inflammation, anti oxidative stress and anti apoptosis when the alpha 7 nicotinic acetylcholine receptors are activated . Ⅱ.Judge whether ...

Eligibility Criteria

Inclusion

  • Ⅰ.Accompanied by obstructive jaundice and plans to implement the liver resection of hilar bile duct carcinoma.
  • Patients with carcinoma of head of pancreas and plans to implement pancreaticoduodenectomy.
  • Ⅱ. Drugs which were used in the clinical trials is safe for patients.
  • Ⅲ.The patients did not occur the complication which would affect the experimental observation seriously after the operation.
  • Ⅳ.The patients agreed to participate in this clinical trial and sign the informed consent.

Exclusion

  • Ⅰ.Patients are unwilling to accept the clinical trials or researchers believe that patients can not in compliance with the requirements of clinical research.
  • Ⅱ.Patients with tumor metastases widely or can not accept a predetermined operation scheme.
  • Ⅲ. The postoperative complications or other therapeutic measures take will affect the experimental observation seriously.

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2017

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT02279147

Start Date

August 1 2014

End Date

September 1 2017

Last Update

October 30 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHN Chinese PLA General Hospital

Beijing, Beijing Municipality, China, 100853